Presented by Prof. Bernardo Cortese, the study compares a sirolimus-coated balloon with a drug-eluting stent in native coronary vessels.
CERC is proud to contribute to this international trial across 14 sites in Bangladesh, Malaysia, Brunei, Thailand and Poland, supporting key activities including kick-off, clinical trial documentation, regulatory submissions, contracts and monitoring.
TRANSFORM II is sponsored by Fondazione Ricerca e Innovazione Cardiovascolare.
📍 TCT 2026
📅 Sunday, November 1
🕚 11:07 AM | Main Arena
Learn more about the study : TRANSFORM II : Magic Touch SCB compared to the gold standard treatment | CERC
hashtag#TCT2026 hashtag#ClinicalResearch hashtag#Cardiology hashtag#CoronaryIntervention
